Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,306 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04686097Recruiting
Comparing two treatments for leg vein problems
This trial compares a needle-based procedure (electrocoagulation) with a foam injection (sclerosing foam) to treat faulty veins in the legs that cause skin damage or ulcers. It aims to find which method works better for people with moderate to severe vein disease.
Hefei, AnhuiAges 18–80 - NCT04698785RecruitingPhase 2
Regorafenib to help prevent cancer return after treatment
This Phase 2 study tests whether regorafenib, given after your main treatments, can help keep high-grade bone sarcoma from coming back or progressing. It checks safety and whether this “maintenance” approach works better than best supportive care alone.
BesançonAges 12 years+ - NCT04743141RecruitingPhase 3
Long-term migraine medicine study for kids with migraine attacks
This Phase 3 study checks the long-term safety of rimegepant, a migraine treatment, in children and teens. You might join if your child has had migraine for at least 6 months and still gets a certain number of moderate-to-severe migraine attacks.
Scottsdale, ArizonaAges 6–17 - NCT04681339Recruiting
Antibiotics in hospitalized children with community pneumonia
This study looks at how antibiotics are prescribed for children who are hospitalized with community-acquired pneumonia. It may help doctors choose more appropriate antibiotic use for kids in the hospital.
Filderstadt, Baden-WurttembergAges 3 months–18 years - NCT04663724Recruiting
Computer-based treatment for social anxiety disorder
This study is testing a computer-based treatment for social anxiety disorder. It may help reduce anxiety in social situations through a structured online program, and it also includes brain imaging (MRI) to see how the treatment affects the brain.
New York, New YorkAges 18–60 - NCT04683315RecruitingPhase 2
Pancreatic cancer biopsy-guided chemo before surgery
This trial uses a special gene test on fluid taken from an endoscopic ultrasound (EUS) biopsy to help choose chemotherapy before surgery for pancreas cancer. It aims to see if this approach improves outcomes by matching treatment to the tumor’s RNA pattern.
Scottsdale, ArizonaAges 18 years+ - NCT04672551Recruiting
EMDR therapy for PTSD after a heart attack
This trial studies whether EMDR (a structured therapy that helps process distressing memories) can reduce PTSD symptoms in people who developed PTSD after a cardiac event. It may help you feel less overwhelmed by memories and stress related to the heart event.
ZurichAges 18–70 - NCT04503395Recruiting
Testing two new ways to repair an abdominal aneurysm
This trial compares two procedures (ESAR and FEVAR) to repair an abdominal aortic aneurysm in people whose anatomy makes the usual repair hard. It may help find a safer, more durable option for patients with challenging aortic neck features.
La Jolla, CaliforniaAges 18 years+ - NCT04475510Recruiting
Stop blood-thinner therapy after PFO closure in younger stroke patients
This trial tests whether it’s safe to stop antithrombotic (blood-thinner) treatment after a successful hole-in-the-heart procedure (PFO closure) in people age 60 and under who had an unexplained stroke or TIA. It may help some people avoid long-term blood-thinner side effects if their risk stays low.
Québec, QuebecAges 18–60 - NCT04381663Enrolling by invitation
Tracking symptoms in degenerative neck spine narrowing
This study follows adults with degenerative narrowing in the neck spine to see how symptoms and function change over time. It may help doctors better understand which patients improve or worsen, and why.
BaselAges 18 years+ - NCT04267848RecruitingPhase 3
Testing immunotherapy with chemo after lung cancer surgery
This trial tests whether adding an immunotherapy medicine to standard chemotherapy after surgery can improve outcomes for some people with non-small cell lung cancer. It may help by boosting the immune system to reduce the chance the cancer comes back.
Anchorage, AlaskaAges 18 years+ - NCT04328298Recruiting
Register study of people in France eligible for CAR-T therapy
This study collects health data from people in France who received CAR-T treatment or are eligible to receive it. It helps doctors and researchers understand who can get CAR-T and how treatment is used in real life.
AmiensAges birth–99 years - NCT04359186Recruiting
Stopping HIV medicines briefly with close monitoring
This study looks at a planned, supervised “treatment interruption” period for people with HIV who are very well controlled on HIV medicines. It mainly aims to understand what happens when therapy is paused and how to reduce the risk of passing HIV to others.
San Francisco, CaliforniaAges 18 years+ - NCT04230356RecruitingPhase 2
Viral immune T-cells for viral infections after stem cell transplant
This Phase 2 study tests donor-made immune T-cells that specifically target viruses to treat or prevent viral infections after a stem cell transplant. It may help your body control dangerous viruses like adenovirus, CMV, EBV, and BK virus, while checking safety with different timing of the treatment.
Cincinnati, OhioAges Any age - NCT04230785Recruiting
Blood RNA test during clot-busting treatment for stroke
This trial studies special molecules in the blood (non-coding RNA) in people having an acute ischemic stroke treated with a procedure to remove clots. It may help doctors better understand how the body responds and potentially improve future stroke care.
Nanjing, JiangsuAges 18–90 - NCT04058639Recruiting
Custom felt dressing trial for diabetic foot ulcers
This trial tests whether a special padded (felt) dressing can help heal diabetic foot ulcers with nerve-related injury. If you have a foot wound caused by diabetic nerve problems, the study may offer a shorter treatment time.
MoldeAges 45–80 - NCT04124341Recruiting
Brain stimulation for treatment-resistant depression
This study tests a new brain stimulation treatment for people with severe depression that hasn't improved with standard treatments. You must have tried at least four different depression treatments without success, and either had or refused electroconvulsive therapy (ECT). You’ll need to be under a psychiatrist’s care and be enrolled in Medicare. The study involves brain scans and EEG sessions to tailor the treatment to you.
Minneapolis, MinnesotaAges 22–70 - NCT04055220Recruiting
Regorafenib to keep bone cancer from coming back
This trial studies whether regorafenib given after first treatment helps patients with bone sarcoma stay in remission longer. It focuses on safety and whether the medicine can prevent the cancer from growing or returning.
BesançonAges 12 years+ - NCT04041479RecruitingPhase 3
Brain-scan guided rTMS for treatment-resistant depression
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
Stanford, CaliforniaAges 22–65 - NCT04131829RecruitingPhase 1/Phase 2
Brain scan study to predict fluoxetine response in OCD
This study looks at how brain networks change before and after starting fluoxetine (an SSRI antidepressant) in people with obsessive-compulsive disorder (OCD). It also compares these brain scan patterns with people without OCD to help predict who may respond to treatment.
New Haven, ConnecticutAges 18–65 - NCT03887715Recruiting
VNS device for long-term depression that hasn’t improved
This trial studies whether a vagus nerve stimulation (VNS) device can reduce symptoms of treatment-resistant depression. Participants either receive the VNS treatment or a no-stimulation control, to compare safety and effectiveness.
Birmingham, AlabamaAges 18 years+ - NCT03984656RecruitingPhase 3
Nerve-block pain control during lung fluid drainage in ICU
This trial tests whether a specific pain-relief nerve block (given with numbing medicine) can make pleural drainage in the ICU more comfortable. It may help reduce pain during the procedure for people who are awake and breathing on their own.
AmiensAges 18 years+ - NCT03887481Recruiting
Brain stimulation study for a language-loss dementia subtype
This trial tests whether a painless form of brain stimulation can improve language and thinking skills in people with the logopenic variant of primary progressive aphasia (a dementia that affects language). You may receive brain stimulation along with repeated clinic visits to track changes over time.
Baltimore, MarylandAges 50–80 - NCT03952962Recruiting
Brain stimulation trial for depression that hasn’t improved
This trial tests a targeted deep brain stimulation procedure to reduce symptoms in people with long-lasting, treatment-resistant depression. It may help by improving mood symptoms using stimulation guided by detailed brain imaging.
Dallas, TexasAges 21–70
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,306 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.